Related Experiment Video
Updated: May 9, 2026

CO2-Lasertonsillotomy Under Local Anesthesia in Adults
Published on: November 6, 2019
[Non-surgical treatment for adenoidal hypertrophy]
1Department of Otolaryngology, Nanjing Children's Hospital Affiliated to Nanjing Medical University, Nanjing, 210008, China. llxuu@sina.com
Objective:
Study the practicability of non-surgical treatment for adenoidal hypertrophy.
Method:
Fifty-seven children were recruited in a randomized,placebo-controlled trial. Group T1 underwent intranasal corticosteroids treatment, group T2 underwent leukotriene receptor antagonists treatment, group C underwent placebo treatment:the records of 3 groups were analyzed.
Result:
After a 12-week treatment with intranasal corticosteroids or leukotriene receptor antagonists, group T1 and T2 patients demonstrated significant improvements in clinical symptoms and a more-pronounced reduction in adenoid size compared with control group patients, the difference was statistically significant. No statistically significant difference in group T1 and T2 patients.
Conclusion:
Intranasal corticosteroids and leukotriene receptor antagonists may be considered useful in decreasing adenoid pad size and the severity of symptoms related to adenoidal hypertrophy. Children with adenoidal hypertrophy should be considered for non-surgical treatment before surgery is planned.
Related Concept Videos
Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Tonsillitis II: Management
Trachea
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of the...
Adrenergic Agonists: Therapeutic Classification
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Mitral Stenosis III: Medical Management

